Tiziana Life Sciences is trading 5.73% down at $1.07 after no clear company-specific catalyst emerged on August 17, 2026.
- Latest identified disclosures were CEO share purchases announced August 4 and August 6; the investor-relations page lists no newer announcement explaining the decline.
- Broader markets are mixed, with the S&P 500 and Dow lower but the Nasdaq higher, so global sentiment does not clearly explain the move.